26 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
additional funding before the Company achieves sustainable revenues and profit from operations.
Research and development activities have required
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
funding before the Company achieves sustainable revenues and profit from operations.
Research and development activities have required significant
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
the Company achieves sustainable revenues and profit from operations.
Research and development activities have required significant capital investment since
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
activities are subject to significant risks and uncertainties, including failing to secure additional funding before the Company achieves sustainable
6-K
EX-99.1
u76v32gc
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
z2fb301q
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
bns9h
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
gjo 2ad33h
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
wh2nq8w2j0ivq1dvl40g
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
5qvsqh1
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
c02bleg1b7a w3l
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.1
m56eg0u1dt7
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K/A
EX-99.1
1cfeblscnqaerd2lh
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
pyi34 pjyke8z2794
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
zaao8nt7xf lyms
18 May 20
Condensed Consolidated Financial Statements
4:30pm